Full text is available at the source.
CAR T Cell Therapy for Solid Tumors
Using CAR T Cell Therapy to Treat Solid Tumors
AI simplified
Abstract
CAR T cells have shown significant success in eradicating hematologic malignancies but face challenges in targeting solid tumors.
- CAR T cells are engineered to recognize and attack specific cancer cells by expressing synthetic receptors.
- While effective against blood cancers, their efficacy in solid tumors remains limited.
- Challenges in the solid tumor microenvironment may hinder the persistence and activity of CAR T cells.
- New strategies are being explored to enhance CAR T cell function in solid tumors.
AI simplified